Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | GILD | LLY |
|---|
| Close | 170.68 | 1,417.54 |
| Market Cap | $213B | $1.34T |
| 1M | +14.51% | +22.51% |
| P/E (TTM) | — | 50.2 |
| Forward P/E | 22.0 | 26.3 |
| P/E 5-Yr Percentile | — | 28 |
| P/S | 7.0 | 16.8 |
| P/B | 17.9 | 39.6 |
| Dividend Yield | 3.98% | 0.75% |
| Latest Quarter Revenue | $8.3B | $24.4B |
| Revenue YoY | +6.8% | +38.6% |
| Gross Margin | 81.1% | 83.9% |
| Latest Quarter EPS | 1.94 | 7.22 |
| Avg Post-Earnings Move | ±3.8% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.57% | 0.88% |
| 90-Day Net Insider Buying | −$15.9M | −$16.0M |
GILD · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
